Evolving Treatment Options for Metastatic Renal Cell Carcinoma (mRCC)
Approximately a third of patients diagnosed with kidney cancer in the United States present with advanced disease and those who present with distant metastases historically had dismal 5-year relative survival. However, over the last several years, advancements have led to improved life expectancy an...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-04-01
|
| Series: | Uro |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-4397/3/2/14 |